Role of central mu, delta-1, and kappa-opioid receptors in opioid- induced muscle rigidity in the rat

Anesthesiology

Volumn 85, Issue 3, 1996, Pages 574-583

  Vankova, Miriana E ^a   Weinger, Matthew B ^a,b,c,d   Chen, Dong Yi ^a   Bronson, J Brian ^a   Motis, Valerie ^a   Koob, George F ^c  

^a School of Medicine   (United States)

^b S Diego Vet Affairs Medical Center   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Analgesics, opioid: receptors; Anesthetics, intravenous: alfentanil; Animals: rat; Antagonists: narcotic; Brain: drug injections; Complications: muscle rigidity; Measurement techniques: electromyography

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ALFENTANIL; DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE AGONIST; OPIATE ANTAGONIST;

ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG MEGADOSE; DRUG RECEPTOR BINDING; ELECTROMYOGRAM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS ANESTHESIA; MALE; MUSCLE RIGIDITY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029766874     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199609000-00017     Document Type: Article

References (53)

1. Reisine T: Opiate receptors. Neuropharmacology 1995; 34:463-72
2. George SR, Zastawny RL, Biones-Urbina R, Cheng R, Nguyen T, Heiber M, Kouvelas A, Chan AS, O'Dowd BF: Distinct distributions of mu, delta, and kappa opioid receptor mRNA in rat brain. Biochem Biophys Res Commun 1994; 205:1438-44
3. Mansour A, Fox CA, Burke S, Meng F, Thompson RC, Akil H, Watson SJ: Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: In situ hybridization study. J Comp Neurol 1994; 350:412-38
4. Uhl GR, Childers S, Pasternak G: An opiate-receptor gene family reunion. Trends Neurosci 1994; 17:89-93
5. Pasternak GW: Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 1993; 1:1-18
6. Traynor JR, Elliott J: Delta-opioid receptor subtypes and cross-talk with μ-receptors. Trends Pharmacol Sci 1993; 14:84-6
7. Wollemann M, Benye S, Simon J: The kappa-opioid receptor: Evidence for the different subtypes. Life Sci 1993; 52:599-611
8. Pasternak GW: Multiple mu opiate receptors. ISI Atlas Sci: Pharmacol 1988; 890:148-54
9. Chaillet P, Marcais-Collado H, Costentin J: Catatonic or hypotonic immobility induced in mice by intracerebroventricular injection of mu or kappa opioid receptor agonists as well as enkephalins or inhibitors of their degradation. Life Sci 1983; 33:2105-11
10. Devine DP, Wise RA: Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J Neurosci 1994; 14:1978-84
11. Frank LS, Miaskowsi C, Putris J, Levine JD: Dissociation of antinociceptive and motor effects of supraspinal opioid agonists in the rat. Brain Res 1991; 563:123-6
12. 5]enkaphalin as a highly selective ligand for the delta-binding site. Br J Pharmacol 1985; 84:927-32
13. 2]deltorphin II in mice: Evidence for delta receptor subtypes. J Pharmacol Exp Ther 1991; 258:583-7
14. 4]deltorphin with delta-opioid receptor subtypes in vivo. Eur J Pharmacol 1994; 252:133-7
15. Von Voightlander PF, Lewis RA: U50,488H: A selective and structurally novel non-mu (kappa) opioid kappa agonist. J Pharmacol Exp Ther 1983; 224:7-12
16. Chien C-C, Brown G, Pan Y-X, Pasternak GW: Blockade of U50488H analgesia by antisense oligodeoxynucleotides to a kappa-opioid receptor. Eur J Pharmacol 1994; 253:R7-8
17. Weinger MB, Smith NT, Blasco TA, Koob GF: Brain sites mediating opiate-induced muscle rigidity in the rat: Methylnaloxonium mapping study. Brain Res 1991; 544:181-90
18. Yang P, Weinger MB, Negus SS: Elucidation of dose-effect relationships for different opiate effects using alfentanil in the spontaneously ventilating rat. ANESTHESIOLOGY 1992; 77:153-61
19. Weinger MB, Bednarzyck J: Atipamezole, an alpha-2 antagonist, augments opiate-induced muscle rigidity in the rat. Pharmacol Biochem Behav 1994; 49:523-9
20. Pellegrino L, Pellegrino A, Cushman A: A Stereotaxic Atlas of the Rat Brain. New York, Plenum Press, 1979
21. Wood DL, Weinger MB, Furst SR: Antagonism of the respiratory effects of mu and delta opioid agonists (abstract). ANESTHESIOLOGY 1994; 81:A1408
22. Wood DL, Weinger MB, Furst SR, Coleman MJ: Biphasic respiratory effects of a central delta opioid receptor agonist (abstract). ANESTHESIOLOGY 1994; 81:A1409
23. Negus SS, Weinger MB, Hendricksen SJ, Koob GF: Effect of mu, delta, and kappa opioid agonists on heroin-maintained responding in the rat. Problems of Drug Dependence 1991. NIDA Res Monogr 1992; 119:410
24. Negus SS, Henriksen SJ, Mattox A, Pasternak GW, Portoghese PS, Takemori AE, Weinger MB, Koob GF: Effect of antagonists selective for mu-opioid, delta-opioid, and kappa-opioid receptors on the reinforcing effects of heroin in rats. J Pharmacol Exp Ther 1993; 265:1245-52
25. Negus SS, Pasternak GW, Koob GF, Weinger MB: Antagonist effects of betafunaltrexamine and naloxonazine on alfentanil-induced antinociception and muscle rigidity in the rat. J Pharmacol Exp Ther 1993; 264:739-45
26. Weinger MB, Chen D-Y, Lin T, Lau C, Koob GF, Smith NT. A role for CNS alpha-2 adrenergic receptors in opiate-induced muscle rigidity in the rat. Brain Res 1995; 669:10-8
27. Winer BJ: Statistical Principles in Experimental Design. 2nd edition. New York, McGraw-Hill, 1971
28. Seeber U, Kuschinsky K, Sontag KH: Inhibition by opiate narcotics of rat flexor alpha-motoneurons. Naunyn Schmeidberg's Arch Pharmacol 1978; 301:181-5
29. Blasco TA, Lee DE, Almaric M, Swerdlow NR, Smith NT, Koob GF: The role of the nucleus raphe pontis and the caudate nucleus in alfentanil rigidity in the rat. Brain Res 1986; 386:280-6
30. 6]enkephalin and naltrindole 5′-iso-thiocyanate: Evidence for delta receptor subtypes. J Pharmacol Exp Ther 1991; 257:1009-75
31. Portoghese PS, Sultana M, Takemori AE: Naltrindole, a highly selective and potent non-pcptide delta opioid receptor antagonist. Eur J Pharmacol 1988; 146:185-6
32. 1 binding assay. Mol Pharmacol 1988; 34:308-17
33. 3 subtype. J Pharmacol Exp Ther 1989; 251:461-8
34. Horan P, Taylor J, Yamamura HI, Porreca F: Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail flick test. J Pharmacol Exp Ther 1992; 260:1237-43
35. 1 receptor mRNA distribution in the rat CNS: Comparison to κ receptor binding and prodynorphin mRNA. Mol Cell Neurosci 1994; 5:124-44
36. Horan P, Tallarida RJ, Haaseth R, Matsunaga T, Hruby VJ, Porreca F: Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: Supra- and subadditivity. Life Sci 1992; 50:1535-41
37. Porreca F, Takemori AE, Portoghese PS, Sultana M, Bowen WD, Mosberg HI: Modulation of mu-mediated antinociception by a subtype of opioid delta receptor in the mouse. J Pharmacol Exp Ther 1992; 263:147-52
38. Lee PH, Nguyen TM, Chung NN, Schiller PW, Chang KJ: Tyrosine-iodination converts the delta-opioid peptide antagonist TIPP to an agonist. Eur J Pharmacol 1995; 280:211-4
39. Spanagel R, Shippenberg T: Modulation of morphine-induced sensitization by endogenous κ opioid system in the rat. Neurosci Lett 1993; 153:232-6
40. Sheldon RJ, Nunan L, Porreca F: Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo. J Pharmacol Exp Ther 1987; 243:234-40
41. Kim HS, Iyengar S, Wood PL: Reversal of the actions of morphine on mesocortical dopamine metabolism in the rat by the kappa agonist MR-2034: Tentative mu-2 opioid control of mesocortical dopaminergic projections. Life Sci 1987; 41:1711-5
42. Dosaka-Akita K, Tortella FC, Holaday JW, Long JB: The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats. J Pharmacol Exp Ther 1993; 264:631-7
43. Porreca F, Tonella FC: Differential antagonism of mu agonists by U50488H in the rat. Life Sci 1987; 41:2511-6
44. Bhargava HN, Ramarao P, Gulati A: Effects of morphine in rats treated chronically with U-50, 488H, a kappa opioid receptor agonist. Eur J Pharmacol 1989; 162:257-64
45. Endoh T, Matsuura H, Tanaka C, Nagase H: Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther 1992; 316:30-42
46. Portoghese PS, Lipkowski AW, Takemori AE: Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor antagonists, Life Sci 1987; 40:1287-92
47. Slater P, Starkie DA: Changes in limb tone produced by regional injections of opiates into rat brain. Naunyn-Schmiedbergs Arch Pharmacol 1987; 335:54-8
48. Widdowson PS, Griffiths EC, Slater P: The effects of opioids in the periaqueductal gray region of rat brain on hind-limb muscle tone. Neuropeptides 1986; 7:251-8
49. Lui PW, Lee TY, Chan SHH: Involvement of locus coeruleus and noradrenergic neurotransmission in fentanyl-induced muscular rigidity in the rat. Neurosci Lett 1989; 96:114-9
50. Lui P, Lee T, Chan S: Involvement of coerulospinal noradrenergic pathway in fentanyl-induced muscular rigidity in rats. Neurosci Lett 1990; 108:183-8
51. Dauge V, Petit F, Rossignol P, Roques BP: Use of μ and δ opioid peptides of various selectivity gives evidence of specific involvement of μ opioid receptors in supraspinal analgesia (tail-flick test). Eur J Pharmacol 1987; 141:171-8
52. Ling GSF, Pasternak GW: Morphine catalepsy in the rat: Involvement of mu1 (high affinity) opioid binding sites. Prog Neurobiol 1982; 32:193-6
53. Ling GSF, Spiegel K, Lockhart SH, Pasternak GW: Separation of opioid analgesia from respiratory depression: Evidence for different receptor mechanisms. J Pharmacol Exp Ther 1985; 232:149-55